Belcher Notches Double-Double at NJIT
Oct. 25, 2011
NEWARK, N.J. - The Lafayette volleyball team fell in straight sets at NJIT on Tuesday by set scores of 25-22, 25-20 and 25-18. Molly Belcher recorded her third double-double of the season, and Christy Mebust tallied 22 digs in the three-set encounter.
With the loss, the Leopards fall to 8-14. NJIT improves to 8-15.
Belcher's double-double consisted of 20 assists and 16 digs out of the setter spot. She also had four kills on 12 errorless swings (.333) and a service ace. She distributed assists to six different players as the offense was led by six kills apiece from Kaitlynn Zoller and Camissa Beghou. Danielle Towslee slammed home five kills, Katy Rooney recorded four, Andrea Duvall had two and Alana Taylor rounded out the offense with one finisher.
Mebust's 22 digs and Belcher's 16 led a strong effort by the Leopards. Zoller contributed 13 digs and Duvall pitched in with nine. At the net, Rooney and Zoller teamed up for Lafayette's only block of the contest.
Towslee improved on her team-high total with four of the Leopards' seven aces. Belcher, Mebust and Duvall each landed one winner.
Janet Snell paced the NJIT offense with a match-high 20 kills (20-5-50, .300). Setter Anna Mercado notched a double-double with 32 assists and 13 digs. Audrey Snell led the Highlanders' back row with 19 digs.
Lafayette returns home to host Lehigh on Friday, Oct. 28 at 7 p.m. The Leopards will host their annual "Dig Pink" match against the Mountain Hawks. Fans who wish to contribute to Lafayette's fundraising efforts can visit the Side-Out Foundation's secure website.
Dig Pink is a national breast cancer awareness initiative started by the Side-Out Foundation and held annually during the month of October. This season, the Side-Out Foundation set a monetary goal of $2.5 million as well as a participation goal of 500 collegiate and 1,000 scholastic programs.
The Side-Out Foundation is a support and advocacy organization dedicated to making a significant and identifiable difference in the lives of breast cancer patients and their families by supporting clinical trials, increasing compassionate support services and educating communities.